Offer - Urjas Oil for just ₹ 1 X
Tenlimac M 500 Tablet SR, a prescription drug, is manufactured in various forms such as Tablet. Secondary and off-label uses of Tenlimac M 500 Tablet SR have also been mentioned below.
The optimal dosage of Tenlimac M 500 Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Common side effects of Tenlimac M 500 Tablet SR include Stomach Upset, Difficulty urinating, Hypoglycemia (Low blood sugar level). Besides the aforementioned side effects, there are other adverse effects of Tenlimac M 500 Tablet SR as well, which are listed below. Normally, these side effects of Tenlimac M 500 Tablet SR are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Tenlimac M 500 Tablet SR has a Moderate effect for pregnant women and Severe effect on lactating mothers. In addition, Tenlimac M 500 Tablet SR's effects on the liver, heart and kidney are discussed below in the Tenlimac M 500 Tablet SR related warnings section.
Tenlimac M 500 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Tenlimac M 500 Tablet SR in conditions like Congestive Heart Failure (CHF), Anemia, Shock. Some other conditions that can be affected by Tenlimac M 500 Tablet SR are listed in the contraindications section below.
Additionally, Tenlimac M 500 Tablet SR may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Tenlimac M 500 Tablet SR is safe while driving, and is addiction.
Tenlimac M 500 Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Tenlimac M 500 Tablet SR safe for pregnant women?
Tenlimac M can have harmful effects in pregnant women. If you experience any discomfort after using Tenlimac M, then discontinue the use and take your doctor's advice.
Is the use of Tenlimac M 500 Tablet SR safe during breastfeeding?
Taking Tenlimac M may lead to serious side effects if you are breastfeeding. Tenlimac M should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Tenlimac M 500 Tablet SR on the Kidneys?
There is no research available on the side effects of Tenlimac M on kidney. Therefore, its impact is unknown.
What is the effect of Tenlimac M 500 Tablet SR on the Liver?
Information about safety of Tenlimac M for the liver is not available since scientific research on this is yet to be done.
What is the effect of Tenlimac M 500 Tablet SR on the Heart?
Side effects of Tenlimac M on heart are unknown because research on this has not been conducted yet.
If you are suffering from any of the following diseases, you should not take Tenlimac M 500 Tablet SR unless your doctor advises you to do so -
Is this Tenlimac M 500 Tablet SR habit forming or addictive?
No, you will not get addicted to Tenlimac M 500 Tablet SR.
Interaction between Food and Tenlimac M 500 Tablet SR
There isn't any research available on the side effects of taking Tenlimac M 500 Tablet SR with food.
Interaction between Alcohol and Tenlimac M 500 Tablet SR
It is difficult to say anything about the effect of Tenlimac M 500 Tablet SR and alcohol. No research has been done on this yet.
Yes, Tenlimac M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Tenlimac M causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Tenlimac M may need to be adjusted.
Tenlimac M should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Tenlimac M helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Tenlimac M is not approved for weight loss, this is an off-label use.
Lactic acidosis associated with Tenlimac M treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Tenlimac M induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Yes, Tenlimac M can cause some sleep problems, especially insomnia. On the other hand, Tenlimac M has proven to be useful for preventing sleep apnea. The exact relationship between Tenlimac M and sleep problems is still not clear, and further studies are needed for a clearer understanding.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826